EDGEWISE THERAPEUTICS
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.
EDGEWISE THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2017-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Website Url:
http://www.edgewisetx.com
Total Employee:
11+
Status:
Active
Contact:
720.262.7002
Email Addresses:
[email protected]
Total Funding:
160.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Arcutis Biotherapeutics
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
New Leaf Ventures
New Leaf Ventures investment in Series C - Edgewise Therapeutics
Viking Global Investors
Viking Global Investors investment in Series C - Edgewise Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Edgewise Therapeutics
OrbiMed
OrbiMed investment in Series C - Edgewise Therapeutics
U.S. Venture Partners
U.S. Venture Partners investment in Series C - Edgewise Therapeutics
Surveyor Capital
Surveyor Capital investment in Series C - Edgewise Therapeutics
CureDuchenne Ventures
CureDuchenne Ventures investment in Series C - Edgewise Therapeutics
Deerfield
Deerfield investment in Series C - Edgewise Therapeutics
Novo Holdings
Novo Holdings investment in Series C - Edgewise Therapeutics
Citadel
Citadel investment in Series C - Edgewise Therapeutics
Official Site Inspections
http://www.edgewisetx.com Semrush global rank: 5.05 M Semrush visits lastest month: 1.64 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
